News
AZ is hoping that Fasenra (benralizumab) could join rival drugs from Sanofi/Regeneron and GlaxoSmithKline as approved therapies for chronic rhinosinusitis with nasal polyps (CRSwNP) that have been ...
1mon
Health on MSNWhat To Know About Chronic RhinosinusitisChronic Rhinosinusitis With Nasal Polyps (CRSwNP) Chronic rhinosinusitis with ... nasal cavity with a saltwater solution. You can use a spray or squirt bottle, a neti pot, or a nebulizer.
In CRSwNP polyps obstruct the sinuses and nasal passages and can lead to persistent breathing difficulties, nasal congestion and discharge, reduced or loss of sense of smell and taste, and facial ...
These quiz questions about chronic rhinosinusitis with nasal polyps (CRSwNP) are derived from current literature. Are you up to date? At the end of the quiz, compare your score with those of your ...
Data were derived from Walrave L, et al. Abstract 920: Mepolizumab is efficacious in patients with chronic rhinosinusitis with nasal polyps (CRSWNP) with one or multiple prior nasal polyps (NP ...
Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
In addition to COPD, Dupixent is approved in Japan in certain patients with atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), prurigo nodularis, and chronic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results